abagovomab 27
abciximab 21
abituzumab 12
abrilumab 12
actoxumab 8
adalimumab 9
aducanumab 6
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 24
alirocumab 13
amatuximab 20
andecaliximab 17
anifrolumab 15
anrukinzumab 13
aprutumab 10
aprutumab_ixadotin 10
arcitumomab 13
ascrinvacumab 0
atezolizumab 10
atinumab 11
avelumab 7
basiliximab 18
bavituximab 17
begelomab 11
benralizumab 19
bevacizumab_beta 15
bezlotoxumab 8
bimagrumab 9
bleselumab 8
blinatumomab 19
blosozumab 24
bococizumab 17
brazikumab 13
brentuximab_vedotin 18
briakinumab 13
brodalumab 7
brolucizumab 16
brontictuzumab 21
burosumab 15
cabiralizumab 19
camrelizumab 10
canakinumab 18
cantuzumab_ravtansin 26
carlumab 12
carotuximab 8
cergutuzumab_amunaleukin2 25
cergutuzumab_amunaleukin 25
certolizumab_pegol 22
cetiximab 27
citatuzumab_bogatox 24
cixutumumab 16
clivatuzumab_tetraxetan 11
codrituzumab 19
conatumumab 9
concizumab 14
crenezumab 14
crizanlizumab 17
crotedumab 17
dacetuzumab 21
daclizumab 9
dalotuzumab 18
dapirolizumab_pegol 22
daratumumab 10
dectrekumab 4
demcizumab 20
denosumab 7
depatuxizumab 14
depatuxizumab_mafodotin 14
dezamizumab 12
dinutuximab 23
diridavumab 9
domagrozumab 11
drozitumab 12
duligotuzumab 20
durvalumab 7
dusigitumab 19
efalizumab 31
efungumab 16
eldelumab 11
elezanumab 12
elgemtumab 4
elotuzumab 13
emactuzumab 12
emapalumab 14
emibetuzumab 16
enavatuzumab 22
enfortumab_vedotin 9
enoblituzumab 15
enokizumab 20
enoticumab 15
ensituximab 17
eptinezumab 9
erenumab 16
etaracizumab 12
etrolizumab 19
evinacumab 15
evolocumab 11
farletuzumab 0
fasinumab 14
fezakinumab 14
fibatuzumab 6
ficlatuzumab 24
firivumab 22
flanvotumab 11
fletikumab 24
foralumab 8
foravirumab 13
fremanezumab 24
fresolimumab 10
fulranumab 15
futuximab 10
galcanezumab 10
ganitumab 15
gantenerumab 10
gemetuzumab 25
gemtuzumab2 19
gemtuzumab 12
gevokizumab 15
girentuximab 22
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 14
ibalizumab 21
ibritumomab 16
icrucumab 11
idarucizumab 21
ifabotuzumab 6
imalumab 11
imgatuzumab 17
inclacumab 11
indatuximab_ravtansin 23
indusatumab 13
inebilizumab 16
intetumumab 3
iodine_girentuximab 19
ipilimumab 4
iratumumab 8
isatuximab 19
itolizumab 15
ixekizumab 20
labetuzumab_govitecan 21
lambrolizumab 18
lampalizumab 23
lanadelumab 16
landogrozumab 12
laprituximab 23
lebrikizumab 23
lendalizumab 23
lenzilumab 11
lifastuzumab_vedotin 15
ligelizumab 13
lilotomab 23
lirilumab 17
lodelcizumab 13
lokivetmab 11
lorvotuzumab_mertansin 14
lucatumumab 22
lumretuzumab 13
lupartumab 12
lutikizumab 12
margetuximab 25
milatuzumab 18
mirvetuximab 27
mirvetuximab_soravtansin 27
modotuximab 28
mogamulizumab 17
monalizumab 18
motavizumab 25
moxetumomab_pasudotox 14
namilumab 18
naratuximab 23
naratuximab_emtansin 23
narnatumab 9
navicixizumab2 26
navicixizumab 20
navivumab 11
necitumumab 7
nemolizumab 22
nesvacumab 14
nivolumab 10
obiltoxaximab 15
obinutuzumab 24
ocaratuzumab 14
ofatumumab 11
olaratumab 8
olokizumab 19
omalizumab 16
onartuzumab 21
ontuxizumab 15
opicinumab 13
orticumab 6
otelixizumab 21
oxelumab 7
ozanezumab 17
pamrevlumab 6
panobacumab 18
parsatuzumab 25
pasotuxizumab 16
pateclizumab 14
patritumab 14
pembrolizumab 18
perakizumab 16
pidilizumab 13
pinatuzumab_vedotin 11
plozalizumab 13
pogalizumab 22
polatuzumab_vedotin 17
ponezumab 21
prezalumab 14
pritoxaximab 20
quilizumab 15
racotumomab 22
radretumab 7
ralpancizumab 22
ramucirumab 7
ranevetmab 28
ranibizumab 13
refanezumab 15
remtolumab 10
rilotumumab 11
rinucumab 4
risankizumab 26
rituximab 9
rivabazumab 21
robatumumab 18
roledumab 17
romosozumab 17
rontalizumab 21
rosmantuzumab 13
rozanolixizumab 17
sacituzumab 25
sacituzumab_govitecan 25
samalizumab 21
sapelizumab 18
sarilumab 9
secukinumab 13
seribantumab 13
setoxaximab 29
sifalimumab 7
siltuximab 7
simtuzumab 24
sirukumab 8
solanezumab 22
solitomab 18
stamulumab 11
suptavumab 18
suvizumab 13
tabalumab 6
tadocizumab 11
tamtuvetmab 25
tanezumab 17
tarextumab 8
tavolixizumab 8
telisotuzumab 24
teplizumab 12
tesidolumab 17
tezepelumab 19
tigatuzumab 13
tildrakizumab 16
timolumab 8
tisotumab 9
tosatoxumab 20
tositumomab 13
tralokinumab 16
trastuzumab 24
tregalizumab 18
trevogrumab 8
ublituximab 12
urelumab 10
ustekinumab 21
utomilumab 16
vadastuximab 15
vadastuximab_talirin 15
vandortuzumab_vedotin 12
vantictumab 15
vanucizumab2 15
vanucizumab 13
varlilumab 16
vatelizumab 11
vedolizumab 10
veltuzumab 7
vesencumab 4
vorsetuzumab 21
vorsetuzumab_mafodotin 21
vunakizumab 23
xentuzumab 15
zatuximab 28
